Drugmaker Eli Lilly and Co. is planning to spend about $260 million to expand insulin production and make other capital improvements to sites in its home city of Indianapolis.The company plans to spend about $180 million on new construction, the addition of another insulin cartridge-filling line, and the installation of new equipment. Read the full story